Lekshmi R. Nath

Cochin, KL 682041, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Nobiletin reprograms cancer cell fate signaling: PI3K/Akt/mTOR-MAPK crosstalk, NF-kB/STAT3 inhibition and chemosensitization.

Nobiletin reprograms cancer cell fate signaling: PI3K/Akt/mTOR-MAPK crosstalk, NF-kB/STAT3 inhibition and chemosensitization.

Journal: Cellular signalling

Published: February 17, 2026

PEGylated liposomes enhance the pharmacokinetics, biodistribution, anticancer efficacy, and safety of Kaempferol, a phytomolecule enrolled in clinical trials.

PEGylated liposomes enhance the pharmacokinetics, biodistribution, anticancer efficacy, and safety of Kaempferol, a phytomolecule enrolled in clinical trials.

Journal: Scientific reports

Published: February 03, 2026

Gut microbiota and pediatric metabolic dysfunction-associated steatotic liver disease: clinical evidence and therapeutic implications.

Gut microbiota and pediatric metabolic dysfunction-associated steatotic liver disease: clinical evidence and therapeutic implications.

Journal: Frontiers in pediatrics

Published: January 14, 2026

Click inspired new series of pyridazine-triazole-persulfonimide derivatives as DPP-4 inhibitors with exploratory HepG2 phenotypic screening.

Click inspired new series of pyridazine-triazole-persulfonimide derivatives as DPP-4 inhibitors with exploratory HepG2 phenotypic screening.

Journal: Bioorganic chemistry

Published: November 20, 2025

Uttroside B, a US FDA-designated 'Orphan Drug', mitigates the development of hepatocellular carcinoma and its pulmonary metastasis via EGFR/ERK-mediated inhibition of SREBP-1 and STAT-3.

Uttroside B, a US FDA-designated 'Orphan Drug', mitigates the development of hepatocellular carcinoma and its pulmonary metastasis via EGFR/ERK-mediated inhibition of SREBP-1 and STAT-3.

Journal: Cell death discovery

Published: August 05, 2025

Ultrasound imaging-guided protocol for monitoring tumor growth in orthotopic rat model of hepatocellular carcinoma.

Ultrasound imaging-guided protocol for monitoring tumor growth in orthotopic rat model of hepatocellular carcinoma.

Journal: World journal of hepatology

Published: May 14, 2025

Linking necroptosis with liver aging and chronic inflammation in hepatic pathology.

Linking necroptosis with liver aging and chronic inflammation in hepatic pathology.

Journal: Life sciences

Published: May 12, 2025

Editorial: Immunomodulatory molecules of natural origin: innovative strategies for combatting cancer.

Editorial: Immunomodulatory molecules of natural origin: innovative strategies for combatting cancer.

Journal: Frontiers in oncology

Published: January 30, 2025

Orphan drug uttroside B impedes MASH progression and HCC development in experimental models.

Orphan drug uttroside B impedes MASH progression and HCC development in experimental models.

Journal: JHEP reports : innovation in hepatology

Published: December 19, 2024

Ternary complex of Kaempferol-Hydroxypropyl-β-Cyclodextrin-Liposomes against hepatocellular carcinoma: Preparation, validation, pharmacokinetics and efficacy studies.

Ternary complex of Kaempferol-Hydroxypropyl-β-Cyclodextrin-Liposomes against hepatocellular carcinoma: Preparation, validation, pharmacokinetics and efficacy studies.

Journal: International journal of pharmaceutics

Published: November 19, 2024

Modulating the JAK/STAT pathway with natural products: potential and challenges in cancer therapy.

Modulating the JAK/STAT pathway with natural products: potential and challenges in cancer therapy.

Journal: Discover oncology

Published: July 15, 2024

Smart Polymer-Based Delivery Systems for Curcumin in Colon Cancer Therapy: A Review.

Smart Polymer-Based Delivery Systems for Curcumin in Colon Cancer Therapy: A Review.

Journal: Phytotherapy research : PTR

Published: June 25, 2024

Showing 1-12 of 69

Last Updated: 09/26/2026